Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS endovascular system.

Trial of ultrasound-based, catheter-directed thrombolysis is one of several anticipated st ...

Nithin Kamath’s strict 5 am fitness routine didn’t stop his 2024 stroke, showing that good health isn’t just workouts, it's about timely treatment, balance, hydration, and listening to your body are ...

Patients who had low doses of clot-buster drugs delivered directly to the site of a pulmonary embolism (PE) via a catheter using ultrasound to enhance their effect had significantly better outcomes ...

Boston Scientific Corporation announced that the HI-PEITHO global randomized clinical trial evaluating the use of the Ekos endova ...

Results of lung impedance-guided therapy in HFpEF also anticipated this weekend ...

Boston Scientific (NYSE:BSX) executives highlighted new data from two randomized clinical trials during an American College of Cardiology conference call, describing the results as potentially ...

Panaji: Every year around 12,000 accident, cardiac, brain stroke and other serious cases, are referred from both the district hospitals and Ponda sub-.

Patients with acute intermediate-risk pulmonary embolism (PE) have better short-term outcomes with ultrasound-facilitated, catheter-directed fibrinolysis plus heparin-based anticoagulation compared ...

IVUS cuts costs and readmissions in venous stenting. Discover its value in outpatient procedures and learn more about the ...

Boston Scientific Corporation (NYSE: BSX) today announced positive data from the HI-PEITHO global randomized clinical trial ...

Heart disease claims 28.6 lakh lives annually in India, yet access to timely treatment remains severely inadequate, ...